<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CRT</journal-id>
<journal-title-group>
<journal-title>Cancer Research and Treatment : Official Journal of Korean Cancer Association</journal-title><abbrev-journal-title>Cancer Res Treat</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">1598-2998</issn>
<issn pub-type="epub">2005-9256</issn>
<publisher>
<publisher-name>Korean Cancer Association</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4143/crt.2021.769</article-id>
<article-id pub-id-type="publisher-id">crt-2021-769</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group subj-group-type="heading">
<subject>Lung and Thoracic cancer</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>Usefulness of Pulmonary Rehabilitation in Non&#x02013;Small Cell Lung Cancer Patients Based on Pulmonary Function Tests and Muscle Analysis Using Computed Tomography Images</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6536-9763</contrib-id>
<name><surname>Choi</surname><given-names>Juwhan</given-names></name><xref rid="af1-crt-2021-769" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Zepa</given-names></name><xref rid="af2-crt-2021-769" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Jinhwan</given-names></name><xref rid="af3-crt-2021-769" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Jun Hee</given-names></name><xref rid="af4-crt-2021-769" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Hyun Koo</given-names></name><xref rid="af4-crt-2021-769" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0247-8932</contrib-id>
<name><surname>Yong</surname><given-names>Hwan Seok</given-names></name><xref rid="af2-crt-2021-769" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8693-5792</contrib-id>
<name><surname>Lee</surname><given-names>Sung Yong</given-names></name><xref rid="af1-crt-2021-769" ref-type="aff">1</xref></contrib></contrib-group>
<aff id="af1-crt-2021-769">
<label>1</label>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 
<country>Korea</country></aff>
<aff id="af2-crt-2021-769">
<label>2</label>Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 
<country>Korea</country></aff>
<aff id="af3-crt-2021-769">
<label>3</label>Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 
<country>Korea</country></aff>
<aff id="af4-crt-2021-769">
<label>4</label>Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 
<country>Korea</country></aff>
<author-notes>
<corresp id="c1-crt-2021-769">Correspondence: Hwan Seok Yong, Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea, Tel: 82-2-2626-1342, Fax: 82-2-863-9282, E-mail: <email>yhwanseok@naver.com</email></corresp>
<corresp id="c2-crt-2021-769">Co-correspondence: Sung Yong Lee, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea, Tel: 82-2-2626-3030, Fax: 82-2-2626-1166, E-mail: <email>syl0801@korea.ac.kr</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>10</month>
<year>2021</year></pub-date>
<volume>54</volume>
<issue>3</issue>
<fpage>793</fpage>
<lpage>802</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>06</month>
<year>2021</year></date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2021</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 by the Korean Cancer Association</copyright-statement>
<copyright-year>2022</copyright-year>
<license>
<license-p>This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract>
<sec>
<title>Purpose</title>
<p>The usefulness of rehabilitation in patients with reduced lung function before lung surgery remains unclear, and there is no adequate method for evaluating the effect of rehabilitation. We aimed to evaluate the usefulness of rehabilitation in patients with non&#x02013;small cell lung cancer (NSCLC) undergoing lung cancer surgery.</p></sec>
<sec>
<title>Materials and Methods</title>
<p>We retrospectively analyzed the medical records of NSCLC patients at Korea University Guro Hospital between 2018 and 2020. Patients were divided into two groups depending on whether they underwent rehabilitation. Pulmonary function test data and muscle determined using chest computed tomography images were analyzed. Because the baseline characteristics were different between the two groups, propensity score matching was performed.</p></sec>
<sec>
<title>Results</title>
<p>Of 325 patients, 75 (23.1&#x00025;) and 250 (76.9&#x00025;) were included in the rehabilitation and non-rehabilitation (control) groups, respectively. The rehabilitation group had a worse general condition at baseline. After propensity score matching, 45 patients remained in each group. Pulmonary function (forced expiratory volume in 1 second, &#x00025;) (p=0.001) and the Hounsfield unit of erector spinae muscle (p=0.001) were better preserved in the rehabilitation group. Muscle loss of 3.4&#x00025; and 0.6&#x00025; was observed in the control and rehabilitation groups, respectively (p=0.003). In addition, the incidence of embolic events was lower in the rehabilitation group (p=0.044).</p></sec>
<sec>
<title>Conclusion</title>
<p>Pulmonary rehabilitation is useful in patients with NSCLC undergoing lung surgery. Pulmonary rehabilitation preserves lung function, muscle and reduces embolic events after surgery. Pulmonary rehabilitation is recommended for patients with NSCLC undergoing surgery.</p></sec></abstract>
<kwd-group>
<kwd>Non-small-cell lung carcinoma</kwd>
<kwd>Chronic obstructive pulmonary disease</kwd>
<kwd>Pulmonary surgical procedures</kwd>
<kwd>Pulmonary rehabilitation</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Rehabilitation is essential in various clinical situations and diseases &#x0005B;<xref rid="b1-crt-2021-769" ref-type="bibr">1</xref>&#x0005D;. The therapeutic efficacy of surgery or medicine can be improved through rehabilitation. Rehabilitation can maintain the quality of life of patients and prevent the worsening of chronic diseases. For example, rehabilitation can reduce the occurrence of post-intensive care syndrome in the intensive care unit &#x0005B;<xref rid="b2-crt-2021-769" ref-type="bibr">2</xref>&#x0005D;. Rehabilitation can improve sequelae and prevent recurrence in patients with coronary artery disease or cerebrovascular disease &#x0005B;<xref rid="b3-crt-2021-769" ref-type="bibr">3</xref>,<xref rid="b4-crt-2021-769" ref-type="bibr">4</xref>&#x0005D;. Similarly, the value of rehabilitation in various respiratory diseases is also attracting attention &#x0005B;<xref rid="b5-crt-2021-769" ref-type="bibr">5</xref>&#x0005D;.</p>
<p>Pulmonary rehabilitation improves respiratory symptoms and complications in patients with chronic obstructive pulmonary disease (COPD) &#x0005B;<xref rid="b6-crt-2021-769" ref-type="bibr">6</xref>&#x0005D;. Early pulmonary rehabilitation in patients with severe acute exacerbation of COPD can decrease mortality and improve the health-related quality of life &#x0005B;<xref rid="b7-crt-2021-769" ref-type="bibr">7</xref>&#x0005D;. Moreover, pulmonary rehabilitation can improve exercise capacity, dyspnea, and quality of life in patients with idiopathic pulmonary fibrosis &#x0005B;<xref rid="b8-crt-2021-769" ref-type="bibr">8</xref>&#x0005D;. Various studies related to pulmonary rehabilitation in lung cancer and lung operation have been published &#x0005B;<xref rid="b9-crt-2021-769" ref-type="bibr">9</xref>&#x0005D;. Pulmonary rehabilitation can reduce postoperative complications and functional depletion after lung surgery &#x0005B;<xref rid="b10-crt-2021-769" ref-type="bibr">10</xref>&#x0005D;. Pulmonary rehabilitation enables patients with lung cancer with poor lung function to undergo surgery &#x0005B;<xref rid="b11-crt-2021-769" ref-type="bibr">11</xref>&#x0005D;. Furthermore, pulmonary rehabilitation is considered helpful in palliative care for patients with advanced lung cancer.</p>
<p>Pulmonary rehabilitation is known to be useful for treating various respiratory diseases. However, its value and benefits are overlooked in the clinical field &#x0005B;<xref rid="b12-crt-2021-769" ref-type="bibr">12</xref>,<xref rid="b13-crt-2021-769" ref-type="bibr">13</xref>&#x0005D;, possibly owing to the lack of objective and specific data. Therefore, this study aimed to provide objective evidence about the usefulness of pulmonary rehabilitation through chest computed tomography (CT) and pulmonary function test (PFT) assessments in patients with non&#x02013;small cell lung cancer (NSCLC) undergoing lung cancer surgery.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>1. Patients</title>
<p>We retrospectively analyzed the medical records of patients with NSCLC who underwent lung surgery at Korea University Guro Hospital between January 2018 and December 2020. We included patients with histologically proven primary NSCLC according to the tumor-node-metastasis classification of the International Union Against Cancer, 8th edition. We included all types of lung operations (lobectomy, segmentectomy, wedge resection, and bilobectomy). The patients were divided into two groups depending on whether they underwent pulmonary rehabilitation. We included patients with preoperative and postoperative chest CT images or PFT data. In our hospital, PFT and chest CT are performed within a month from the date of discharge for all patients to check the degree of postoperative complications and deterioration of lung function. For this reason, all 325 patients included in this study had preoperative and postoperative PFT and chest CT data. Postoperative PFT and chest CT were mostly performed on the same day, and cases performed 2 months or later from the date of discharge were excluded from this study. Based on the day of discharge, postoperative PFT and chest CT were performed on 24.4&#x000B1;7.3 days later. For PFT-related analysis, we included only patients with forced expiratory volume in 1 second (FEV<sub>1</sub>), forced vital capacity (FVC), and carbon monoxide diffusion capacity (DL<sub>CO</sub>) data</p>
<p>We analyzed several clinical data to assess the effects of rehabilitation treatment on postoperative prognosis. For example, we analyzed the period from admission to discharge, high-flow nasal cannula (HFNC) application, duration of HFNC use, 90-day mortality and 180-day mortality. And major cardiovascular events, arrhythmia, pneumonia, pneumothorax, chest pain, dyspnea, pulmonary embolism, deep vein thrombosis, and pleural effusion were evaluated to evaluate major postoperative complications. &#x02018;Major cardiovascular events, arrhythmias, pneumonia, pneumothorax, chest pain, dyspnea, deep vein thrombosis and pleural effusion&#x02019; were defined only for patients who visited the emergency room or readmitted within 1 month from the date of discharge. &#x02018;Pulmonary embolism&#x02019; was defined as a case seen on postoperative CT.</p>
<p>Primary endpoints were changes in lung function parameters (FEV<sub>1</sub>, FVC, and DL<sub>CO</sub>) and muscle after surgery. Secondary endpoints were prognostic assessment during the hospital stay and major postoperative complications.</p></sec>
<sec>
<title>2. Pulmonary rehabilitation protocol</title>
<p>Pulmonary rehabilitation consisted of exercise and education programs. The exercise program was performed one to three times a week for 30&#x02013;40 minutes per session. The education program was conducted repeatedly in the outpatient clinic and exercise therapy room. The exercise program consisted of aerobic (walking, bicycle ergometer, treadmill, and arm ergometer), strength (mainly upper-limb strengthening training), flexibility, and inspiratory muscle exercises. The education program consisted of smoking-cessation education, breathing re-training (pursed-lip breathing, diaphragmatic breathing, and segmental breathing), and secretion removal training (coughing exercise, huffing, assisted coughing, and postural drainage). The patients&#x02019; exercise intensity was determined according to metabolic equivalent, maximal oxygen consumption, and heart rate values.</p>
<p>Pulmonary rehabilitation was performed at least one to two times before surgery. We assessed the patients&#x02019; condition 2&#x02013;3 weeks after the operation and resumed pulmonary rehabilitation. We provided educational materials (pamphlets, notes, and posters) to patients to enable them to perform daily rehabilitation exercises at home.</p></sec>
<sec>
<title>3. Muscle measurement</title>
<p>There are three muscles (pectoralis muscle, erector spinae muscle (thoracic level), erector spinae muscles (lumbar level)) we considered when measuring the muscle. Of these, the erector spinae muscles (first lumbar level) were chosen for three reasons. As a previous study, there is a study analyzing the prognosis of COPD patients using CT-based muscle measurement of the pectoralis muscle and erector spinae muscle (thoracic level) &#x0005B;<xref rid="b14-crt-2021-769" ref-type="bibr">14</xref>,<xref rid="b15-crt-2021-769" ref-type="bibr">15</xref>&#x0005D;. However, unlike the previous COPD study, this study was conducted on patients who underwent lung surgery and chest tube insertion or management, and it was thought that the pectoralis muscle, erector spinae muscle (thoracic level) may be inaccurate due to damage. Second, routine chest CT included only images up to first lumbar level. Third, in a study analyzing the prognosis of lung cancer patients, not patients with COPD, there was a study that erector spinae muscle (first lumbar level) was better than pectoralis muscle &#x0005B;<xref rid="b16-crt-2021-769" ref-type="bibr">16</xref>&#x0005D;. So, we set the erector spinae muscles (first lumbar level) as the standard for this study (<xref rid="f1-crt-2021-769" ref-type="fig">Fig. 1A and B</xref>).</p>
<p>We used the Hounsfield unit (HU) average value measured within the patient&#x02019;s spinae muscle area in the CT image to evaluate muscle mass. We defined and used &#x02018;HU<sub>ESMcsa</sub>&#x02019; as HU of average intensity value of erector spinae muscle in cross-sectional area in CT.</p>
<p>First, to overcome the variations in image quality based on patient size and scanning protocol, denoising was performed for all chest CT images using commercial software (ClariCT.ai, ClariPi, Seoul, Korea). Second, the HU<sub>ESMcsa</sub> was manually calculated by one experienced clinician and two researcher using in-house developed software that can measure muscle and fat indices and semi-automatically calculate the HU range. The HU<sub>ESMcsa</sub> measurement process was performed twice per person, and the average value was used to avoid user error and to check for repeatability.</p>
<p>The detailed mechanism and principle of measuring HU<sub>ESMcsa</sub> are described below (Mechanism of in-house developed software):</p>
<p>We selected the region of interests (ROI) with in-house developed software, which could get the muscle area by clicking it on screen with mouse cursor from the cross-sectional area in CT image. Then, well-shown homogeneous muscle area and adipose tissue area from the whole area of CT were selected manually for &#x02018;intensity calibration process&#x02019;, for setting HU intensity range of muscle and adipose tissue for simpler way. The HU dividing points of fat and muscle were set to &#x02212;30 at 120 kVp, according to previous studies &#x0005B;<xref rid="b17-crt-2021-769" ref-type="bibr">17</xref>,<xref rid="b18-crt-2021-769" ref-type="bibr">18</xref>&#x0005D;. Around the selected area, the average intensity HU values were measured, and validated via HU value calculation formula from the literatures of &#x02018;National Institute of Standards and technology&#x02019;, since the scanning process of the patients may have various conditions (such as different scanning protocols and parameters which may affect the average intensity value of muscle or adipose tissue value in unexpected range).</p>
<p>After that, with simple image processing techniques, ROI of demanded area was acquired with removing border line of muscle area. Modified flood fill technique was applied to get the ROI of demanded area, which could get the boundary area when relatively large intensity difference was met. This simple technique could get the erector spinae muscle area precisely, especially without boundary edge area which might include inhomogeneous intensity from partial volume area effects.</p>
<p>By getting the ROI from erector spinae muscle area and the intensity range of each target, the muscle and adipose tissue fracture distribution could be calculated by having the threshold value in the middle of muscle and adipose tissue intensity. The muscle and adipose intensity fracture distribution could be directly calculated as muscle density or &#x02018;muscle index&#x02019; from the paper, since it could be interpreted as the mixture organ with pure muscle and fat.</p></sec>
<sec>
<title>4. Statistical analysis</title>
<p>Data were analyzed using SPSS ver. 20 software (IBM Corp., Armonk, NY). Continuous variables are reported as the mean&#x000B1;standard deviation, and categorical variables are reported as the number (&#x00025;). Continuous variables were compared using the Student&#x02019;s t test. Categorical variables were compared using the chi-square test or Fisher exact test. Fisher exact test was used when the expected number of events was less than five.</p>
<p>In general, pulmonary rehabilitation is recommended for patients with poor lung function before lung surgery. Therefore, differences in baseline characteristics and pulmonary function were observed between the two groups. To balance these differences, propensity score matching was performed. Propensity scores were calculated for each patient using multivariable logistic regression based on the following covariates: age, sex, height, weight, FEV<sub>1</sub> (&#x00025;), DL<sub>CO</sub> (&#x00025;), comorbidities, inhaler use, cancer-related treatment (neoadjuvant chemotherapy and neoadjuvant concurrent chemoradiotherapy), type of surgery, and operation site. Matching was performed using the nearest-neighbor method to select the most similar propensity scores. We performed 1:1 matching and calculated the effect size of the standardized mean difference (<italic>d</italic>) to express the suitability of propensity score matchings.</p>
<p>In addition, to increase the reliability of the HU<sub>ESMcsa</sub>, the correlation between the HU<sub>ESMcsa</sub> and PFT values was analyzed. Correlation analysis was performed using Pearson correlation coefficients.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<p>We retrospectively identified 325 patients with NSCLC who underwent lung surgery at our hospital between 2018 and 2020. Of these 325 patients, 75 (23.1&#x00025;) were in the rehabilitation group and 250 (76.9&#x00025;) were in the non-rehabilitation (control) group. After propensity score matching, 45 patients remained in each group (<xref rid="f2-crt-2021-769" ref-type="fig">Fig. 2</xref>). The patients underwent 5.8&#x000B1;5.6 sessions of pulmonary rehabilitation on average.</p>
<sec>
<title>1. Baseline characteristics</title>
<p><xref rid="t1-crt-2021-769" ref-type="table">Table 1</xref> shows the baseline characteristics of patients before and after propensity score matching. The rehabilitation group had a worse general condition than the control group. For example, those in the rehabilitation group were older, had a higher body mass index, and an increased prevalence of COPD. Accordingly, inhaler was used a lot in the rehabilitation group. With respect to the type of surgery, more patients in the rehabilitation group underwent bilobectomy or lobectomy with wedge resection. After propensity score matching, there were no significant differences between the two groups.</p></sec>
<sec>
<title>2. Pulmonary function test</title>
<p><xref rid="t2-crt-2021-769" ref-type="table">Table 2</xref> shows the preoperative PFT results before and after propensity score matching. Our hospital mainly recommends pulmonary rehabilitation for patients with poor lung function. Therefore, the baseline lung function was generally poor in the rehabilitation group. FEV<sub>1</sub> (&#x00025;), FVC (&#x00025;), and DL<sub>CO</sub> (&#x00025;) were all low in the rehabilitation group. We included FEV<sub>1</sub> (&#x00025;) and DL<sub>CO</sub> (&#x00025;) as variables in propensity score matching. Therefore, there was no difference in lung function between the two groups after propensity score matching.</p>
<p><xref rid="t3-crt-2021-769" ref-type="table">Table 3</xref> shows the differences in lung function after surgery. Before and after propensity score matching, FEV<sub>1</sub> (L, &#x00025;) and FVC (L, &#x00025;) were better preserved in the rehabilitation group. Even after propensity score matching, DL<sub>CO</sub> (L, &#x00025;) did not show any statistically significant differences.</p></sec>
<sec>
<title>3. HU<sub>ESMcsa</sub></title>
<p>Before evaluating the HU<sub>ESMcsa</sub>, we performed a correlation analysis between the HU<sub>ESMcsa</sub> and PFT values (<xref rid="f3-crt-2021-769" ref-type="fig">Fig. 3</xref>). FEV<sub>1</sub> (L) and FVC (L) showed a clear positive correlation with the HU<sub>ESMcsa</sub> (R<sup>2</sup>=0.153, p &lt; 0.001 and R<sup>2</sup>=0.262, p &lt; 0.001, respectively).</p>
<p>Before and after propensity score matching, the HU<sub>ESMcsa</sub> was better preserved in the rehabilitation group (p=0.001 and p=0003, respectively) (<xref rid="t4-crt-2021-769" ref-type="table">Table 4</xref>). After propensity score matching analysis, there was 3.4&#x00025; muscle loss in the control group and 0.6&#x00025; muscle loss in the rehabilitation group (p=0.003).</p></sec>
<sec>
<title>4. Prognostic analysis</title>
<p>Before propensity score matching, the period from admission to discharge was longer in the rehabilitation group (p=0.029). After propensity score matching, the period from hospitalization to discharge was similar between the groups (p=0.926). With respect to HFNC application and the duration of HFNC, there were no differences between the two groups. No patients died within 30 days, and there was no difference between the two groups in terms of 90-day and 180-day mortality (<xref rid="t5-crt-2021-769" ref-type="table">Table 5</xref>).</p></sec>
<sec>
<title>5. Major postoperative complications</title>
<p>For major postoperative complications, there was no statistical difference in the analysis before propensity scoring matching, but after propensity scoring matching, there was a statistically significant decrease in major postoperative complications (p=0.027). In particular, the incidence of embolic events (pulmonary embolism or deep vein thrombosis) was lower in the rehabilitated patient group (p=0.044) (<xref rid="t6-crt-2021-769" ref-type="table">Table 6</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>This study is a first study to analyze the efficacy of lung rehabilitation by retrospectively analyzing the data of lung cancer patients who were operated in Korea. In this study, we attempted to demonstrate the usefulness of pulmonary rehabilitation using chest CT and PFT data. Despite the obvious necessity of pulmonary rehabilitation, it is not actively performed in the clinical setting, possibly because of the lack of specific and objective evidence. Therefore, we attempted to prove the necessity of pulmonary rehabilitation using numerical and objective data from CT and PFT assessments. According to our results, pulmonary rehabilitation preserves the FEV<sub>1</sub>, FVC, and HU<sub>ESMcsa</sub>. Pulmonary rehabilitation should be actively recommended to patients with NSCLC scheduled for lung surgery.</p>
<p>It is commonly thought that pulmonary rehabilitation consists of only exercises that strengthen respiratory muscles. Ideally, pulmonary rehabilitation should be a combination of exercise and education programs &#x0005B;<xref rid="b19-crt-2021-769" ref-type="bibr">19</xref>&#x0005D;. Exercise programs include aerobic (walking, bicycle ergometer, treadmill, and arm ergometer), upper-limb strengthening training, flexibility, and inspiratory muscle exercises &#x0005B;<xref rid="b20-crt-2021-769" ref-type="bibr">20</xref>&#x0005D;. Education programs include smoking-cessation education, breathing re-training (pursed-lip breathing, diaphragmatic breathing, and segmental breathing), secretion removal training (coughing exercise, huffing, and assisted coughing), and postural drainage &#x0005B;<xref rid="b21-crt-2021-769" ref-type="bibr">21</xref>&#x0005D;. Furthermore, the addition of dietary education and emotional support programs would contribute to better outcomes &#x0005B;<xref rid="b22-crt-2021-769" ref-type="bibr">22</xref>,<xref rid="b23-crt-2021-769" ref-type="bibr">23</xref>&#x0005D;. The ideal form of pulmonary rehabilitation involves a harmonized combination of exercises and education aiming to correct the patients&#x02019; lifestyle and to encourage them to continuously engage in daily exercise. Therefore, we offered various educational programs in addition to the exercise programs to our patients. The patients in our study underwent fewer pulmonary rehabilitation sessions than those in other studies; however, this was compensated for through our education programs (<xref rid="s1-crt-2021-769" ref-type="supplementary-material">S1</xref> and <xref rid="s2-crt-2021-769" ref-type="supplementary-material">S2 Figs.</xref>). Although the number of patients who underwent optimal rehabilitation treatments in this study was small, active respiratory rehabilitation was able to reduce the postoperative major complication rate in a small number of patients.</p>
<p>Pulmonary rehabilitation is useful for patients with NSCLC who are scheduled to undergo lung surgery because it can help preserve lung function and the respiratory muscles. Rehabilitation reduces postoperative complications &#x0005B;<xref rid="b24-crt-2021-769" ref-type="bibr">24</xref>&#x0005D; and enables the performance of lung surgery in patients with poor lung function &#x0005B;<xref rid="b11-crt-2021-769" ref-type="bibr">11</xref>&#x0005D;. Rehabilitation, whether performed only before surgery, only after surgery, or both before and after surgery, is helpful to patients &#x0005B;<xref rid="b10-crt-2021-769" ref-type="bibr">10</xref>&#x0005D;. As shown in our study, pulmonary rehabilitation preserved the patients&#x02019; FEV<sub>1</sub> and FVC, although there was no clear evidence about the preservation of DL<sub>CO</sub> after propensity score matching. DL<sub>CO</sub> is mainly associated with structural changes in the lungs. Owing to the short follow-up period of our study, the DL<sub>CO</sub> results did not seem to indicate any significant improvement.</p>
<p>Previous pulmonary rehabilitation studies have used questionnaire scores or a 6-minute walk test. Questionnaire scores have limitations depending on the patient&#x02019;s knowledge level and age. Application of the 6-minute walk test may not be possible in patients with poor physical condition. We attempted to prove the usefulness of rehabilitation through CT studies rather than conventional methods. Our study proved the usefulness of rehabilitation using objective data obtained by measuring the HU<sub>ESMcsa</sub>. CT is considered a useful tool for overcoming the limitations of the existing methods.</p>
<p>Several studies have measured the muscle using chest CT in patients with respiratory diseases. For the measurement, the pectoralis major muscle or lumbar back muscle is typically selected &#x0005B;<xref rid="b14-crt-2021-769" ref-type="bibr">14</xref>,<xref rid="b15-crt-2021-769" ref-type="bibr">15</xref>&#x0005D;. In the case of the back muscle, some studies have measured and analyzed all muscle areas at the spine level (cross-sectional level) &#x0005B;<xref rid="b25-crt-2021-769" ref-type="bibr">25</xref>&#x0005D;. As one previous study reported that the lumbar back muscle had a good correlation with lung function, we selected the lumbar back muscle for analysis in our study &#x0005B;<xref rid="b16-crt-2021-769" ref-type="bibr">16</xref>&#x0005D;. The major problem in evaluating CT images is that the CT image quality differs depending on the CT machine used. We mainly evaluated chest CT images obtained at our hospital. By performing denoising and normalization, the CT image quality was equalized as much as possible. In addition, muscle and fat thresholds were set for each CT image.</p>
<p>Our study had several limitations. First, this was a retrospective study. Moreover, pulmonary rehabilitation is primarily recommended for patients with poor lung function at our hospital, which confers bias to this study. To overcome this problem, propensity score matching was performed. In propensity score matching, we tried to include as many factors as possible, including baseline characteristics and PFT parameters. Second, the number of pulmonary rehabilitation sessions was small. It is recommended to perform at least 10 rehabilitation sessions within 4 weeks by previous study &#x0005B;<xref rid="b26-crt-2021-769" ref-type="bibr">26</xref>&#x0005D;. However, center-based pulmonary rehabilitation is still a difficult issue in many countries like Korea &#x0005B;<xref rid="b27-crt-2021-769" ref-type="bibr">27</xref>,<xref rid="b28-crt-2021-769" ref-type="bibr">28</xref>&#x0005D;. To overcome this limitation, we focused on education programs and repeatedly implemented them in our outpatient clinic. The rehabilitation group continued to exercise at home when they did not visit the hospital for rehabilitation sessions. Third, we selected only the lumbar back muscle among several muscle groups. The usefulness of pulmonary rehabilitation can be evaluated more accurately by evaluating various respiratory muscles under various conditions. Fourth, assessments related to patients&#x02019; symptoms and quality of life are lacking. In rehabilitation group, dyspnea score, performance status, six-minute walk test, and maximal oxygen consumption (VO2 max) data could be collected. However, this study was a retrospective study, and the above data could not be collected in the non-rehabilitation group. Instead, we analyzed 90- and 180-day mortality and major postoperative complications (major cardiovascular events, arrhythmia, pneumonia, pneumothorax, pulmonary embolism, deep vein thrombosis, and pleural effusion).</p>
<p>In conclusion, we retrospectively analyzed 325 patients with NSCLC who underwent lung surgery. We analyzed the efficacy of pulmonary rehabilitation using chest CT and PFT data. Pulmonary function and the muscle were better preserved in the rehabilitation group. Pulmonary rehabilitation is overlooked in the clinical field because of the lack of objective data. This study objectively showed that pulmonary rehabilitation is beneficial for patients with lung cancer owing to its muscle preservation effect. Pulmonary rehabilitation should be actively recommended together with education programs for patients with NSCLC with poor lung function before lung surgery.</p></sec></body>
<back>
<sec sec-type="supplementary-material">
<title>Electronic Supplementary Material</title>
<p>Supplementary materials are available at Cancer Research and Treatment website (<ext-link xlink:href="https://www.e-crt.org" ext-link-type="uri">https://www.e-crt.org</ext-link>).</p>
<supplementary-material id="s1-crt-2021-769" content-type="local-data">
<media xlink:href="crt-2021-769_S1_Fig.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
<supplementary-material id="s2-crt-2021-769" content-type="local-data">
<media xlink:href="crt-2021-769_S2_Fig.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec>
<fn-group>
<fn id="fn2-crt-2021-769">
<p><bold>Ethical Statement</bold></p>
<p>This study was approved by the Institutional Review Board of Korea University Guro Hospital (approval no. 2017GR0037). Owing to the retrospective nature of this study and the low risk to the patients, the institutional review committee waived the need for signed informed consent forms.</p></fn><fn id="fn3-crt-2021-769">
<p><bold>Author Contributions</bold></p>
<p>Conceived and designed the analysis: Choi J, Yong HS, Lee SY.</p>
<p>Collected the data: Choi J, Yang Z, Lee J, Lee JH, Kim HK.</p>
<p>Contributed data or analysis tools: Choi J, Yang Z.</p>
<p>Performed the analysis: Choi J, Yang Z.</p>
<p>Wrote the paper: Choi J</p>
<p>Interpretation and review and comment: Choi J, Yong HS, Lee SY.</p></fn><fn id="fn4-crt-2021-769">
<p><bold>Conficts of Interest</bold></p>
<p>Confict of interest relevant to this article was not reported.</p></fn></fn-group>
<ack>
<p>This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (No.2017R1E1A1A01077436).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-crt-2021-769">
<label>1</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Mills</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cieza</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Rehabilitation: essential along the continuum of care</article-title>
<person-group person-group-type="editor">
<name>
<surname>Jamison</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Gel-band</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Horton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Laxminarayan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mock</surname>
<given-names>CN</given-names>
</name>
<etal/>
</person-group>
<source>Disease control priorities: improving health and reducing poverty</source>
<edition>3rd ed</edition>
<publisher-loc>Washington, DC</publisher-loc>
<publisher-name>The International Bank for Reconstruction and Development</publisher-name>
<year>2017</year>
<fpage>285</fpage>
<lpage>95</lpage>
</element-citation>
</ref>
<ref id="b2-crt-2021-769">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colbenson</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Post-intensive care syndrome: impact, prevention, and management</article-title>
<source>Breathe (Sheff)</source>
<year>2019</year>
<volume>15</volume>
<fpage>98</fpage>
<lpage>101</lpage>
</element-citation>
</ref>
<ref id="b3-crt-2021-769">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lui</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Elderly stroke rehabilitation: overcoming the complications and its associated challenges</article-title>
<source>Curr Gerontol Geriatr Res</source>
<year>2018</year>
<volume>2018</volume>
<fpage>9853837</fpage>
</element-citation>
</ref>
<ref id="b4-crt-2021-769">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Greissinger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rottner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rillig</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zimmerling</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The beneficial effects of cardiac rehabilitation</article-title>
<source>Cardiol Ther</source>
<year>2020</year>
<volume>9</volume>
<fpage>35</fpage>
<lpage>44</lpage>
</element-citation>
</ref>
<ref id="b5-crt-2021-769">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Moamary</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Alorainy</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Al-Hajjaj</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Pulmonary rehabilitation: a regional perspective evidenced-based review</article-title>
<source>Ann Thorac Med</source>
<year>2014</year>
<volume>9</volume>
<fpage>3</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="b6-crt-2021-769">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troosters</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gayan-Ramirez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pitta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gosselin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gosselink</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Decramer</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Exercise effort training for COPD: physiological basis and results</article-title>
<source>Rev Mal Respir</source>
<year>2004</year>
<volume>21</volume>
<fpage>319</fpage>
<lpage>27</lpage>
</element-citation>
</ref>
<ref id="b7-crt-2021-769">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryrso</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Godtfredsen</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Kofod</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Lavesen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mogensen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tobberup</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis</article-title>
<source>BMC Pulm Med</source>
<year>2018</year>
<volume>18</volume>
<fpage>154</fpage>
</element-citation>
</ref>
<ref id="b8-crt-2021-769">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dowman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Pulmonary rehabilitation for interstitial lung disease</article-title>
<source>Cochrane Database Syst Rev</source>
<year>2014</year>
<issue>10</issue>
<fpage>CD006322</fpage>
</element-citation>
</ref>
<ref id="b9-crt-2021-769">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiep</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Koczywas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Raz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hurria</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Pulmonary rehabilitation and palliative care for the lung cancer patient</article-title>
<source>J Hosp Palliat Nurs</source>
<year>2015</year>
<volume>17</volume>
<fpage>462</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="b10-crt-2021-769">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stonehewer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Reaper</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bevan-Smith</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery</article-title>
<source>Eur J Cardiothorac Surg</source>
<year>2013</year>
<volume>44</volume>
<fpage>e266</fpage>
<lpage>71</lpage>
</element-citation>
</ref>
<ref id="b11-crt-2021-769">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vagvolgyi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rozgonyi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kerti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Agathou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vadasz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Effectiveness of pulmonary rehabilitation and correlations in between functional parameters, extent of thoracic surgery and severity of post-operative complications: randomized clinical trial</article-title>
<source>J Thorac Dis</source>
<year>2018</year>
<volume>10</volume>
<fpage>3519</fpage>
<lpage>31</lpage>
</element-citation>
</ref>
<ref id="b12-crt-2021-769">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pehlivan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Balci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kilic</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Can functional inoperability in lung cancer patients be changed by pulmonary rehabilitation?</article-title>
<source>Turk Gogus Kalp Damar Cerrahisi Derg</source>
<year>2019</year>
<volume>27</volume>
<fpage>212</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="b13-crt-2021-769">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Dolezal</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>Pulmonary rehabilitation for chronic obstructive pulmonary disease: highly effective but often overlooked</article-title>
<source>Tuberc Respir Dis (Seoul)</source>
<year>2020</year>
<volume>83</volume>
<fpage>257</fpage>
<lpage>67</lpage>
</element-citation>
</ref>
<ref id="b14-crt-2021-769">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bak</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>SO</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Computed tomography-derived area and density of pectoralis muscle associated disease severity and longitudinal changes in chronic obstructive pulmonary disease: a case control study</article-title>
<source>Respir Res</source>
<year>2019</year>
<volume>20</volume>
<fpage>226</fpage>
</element-citation>
</ref>
<ref id="b15-crt-2021-769">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanimura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fuseya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uemasu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease: novel chest computed tomography-derived index for prognosis</article-title>
<source>Ann Am Thorac Soc</source>
<year>2016</year>
<volume>13</volume>
<fpage>334</fpage>
<lpage>41</lpage>
</element-citation>
</ref>
<ref id="b16-crt-2021-769">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>KJC</given-names>
</name>
<name>
<surname>Degens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dingemans</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Schols</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer</article-title>
<source>Int J Chron Obstruct Pulmon Dis</source>
<year>2019</year>
<volume>14</volume>
<fpage>781</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="b17-crt-2021-769">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aubrey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Esfandiari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Baracos</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Buteau</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Frenette</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Putman</surname>
<given-names>CT</given-names>
</name>
<etal/>
</person-group>
<article-title>Measurement of skeletal muscle radiation attenuation and basis of its biological variation</article-title>
<source>Acta Physiol (Oxf)</source>
<year>2014</year>
<volume>210</volume>
<fpage>489</fpage>
<lpage>97</lpage>
</element-citation>
</ref>
<ref id="b18-crt-2021-769">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ewaschuk</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Almasud</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mazurak</surname>
<given-names>VC</given-names>
</name>
</person-group>
<article-title>Role of n-3 fatty acids in muscle loss and myosteatosis</article-title>
<source>Appl Physiol Nutr Metab</source>
<year>2014</year>
<volume>39</volume>
<fpage>654</fpage>
<lpage>62</lpage>
</element-citation>
</ref>
<ref id="b19-crt-2021-769">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vogiatzis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Burtin</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The importance of components of pulmonary rehabilitation, other than exercise training, in COPD</article-title>
<source>Eur Respir Rev</source>
<year>2013</year>
<volume>22</volume>
<fpage>405</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="b20-crt-2021-769">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wouters</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Posthuma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Koopman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Sillen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hajian</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>An update on pulmonary rehabilitation techniques for patients with chronic obstructive pulmonary disease</article-title>
<source>Expert Rev Respir Med</source>
<year>2020</year>
<volume>14</volume>
<fpage>149</fpage>
<lpage>61</lpage>
</element-citation>
</ref>
<ref id="b21-crt-2021-769">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>O&#x02019;Neill</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>J</given-names>
</name>
<name>
<surname>MacMahon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Education in pulmonary rehabilitation: the patient&#x02019;s perspective</article-title>
<source>Arch Phys Med Rehabil</source>
<year>2007</year>
<volume>88</volume>
<fpage>1704</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="b22-crt-2021-769">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldhahir</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rajeh</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Aldabayan</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Drammeh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Subbu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Alqahtani</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>
<article-title>Nutritional supplementation during pulmonary rehabilitation in COPD: a systematic review</article-title>
<source>Chron Respir Dis</source>
<year>2020</year>
<volume>17</volume>
<fpage>1479973120904953</fpage>
</element-citation>
</ref>
<ref id="b23-crt-2021-769">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popa-Velea</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Purcarea</surname>
<given-names>VL</given-names>
</name>
</person-group>
<article-title>Psychological intervention: a critical element of rehabilitation in chronic pulmonary diseases</article-title>
<source>J Med Life</source>
<year>2014</year>
<volume>7</volume>
<fpage>274</fpage>
<lpage>81</lpage>
</element-citation>
</ref>
<ref id="b24-crt-2021-769">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rispoli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salvi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cennamo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Di Natale</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Natale</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Meoli</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>
<article-title>Effectiveness of home-based preoperative pulmonary rehabilitation in COPD patients undergoing lung cancer resection</article-title>
<source>Tumori</source>
<year>2020</year>
<volume>106</volume>
<fpage>203</fpage>
<lpage>11</lpage>
</element-citation>
</ref>
<ref id="b25-crt-2021-769">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>YA</given-names>
</name>
<etal/>
</person-group>
<article-title>Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients</article-title>
<source>Respir Res</source>
<year>2019</year>
<volume>20</volume>
<fpage>35</fpage>
</element-citation>
</ref>
<ref id="b26-crt-2021-769">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benzo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wigle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Novotny</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wetzstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>RK</given-names>
</name>
<etal/>
</person-group>
<article-title>Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies</article-title>
<source>Lung Cancer</source>
<year>2011</year>
<volume>74</volume>
<fpage>441</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="b27-crt-2021-769">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>The effects of simultaneous pulmonary rehabilitation during thoracic radiotherapy in the treatment of malignant diseases</article-title>
<source>Tuberc Respir Dis</source>
<year>2021</year>
<volume>84</volume>
<fpage>148</fpage>
<lpage>58</lpage>
</element-citation>
</ref>
<ref id="b28-crt-2021-769">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SW</given-names>
</name>
<etal/>
</person-group>
<article-title>Feasibility of an outpatient-based pulmonary rehabilitation program for lung cancer patients during radiation therapy</article-title>
<source>Thorac Cancer</source>
<year>2021</year>
<volume>12</volume>
<fpage>2241</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-crt-2021-769" position="float">
<label>Fig. 1</label>
<caption>
<p>HU<sub>ESMcsa</sub> calculation. We drew the erector spinae muscles (first lumbar level) with a green line. For each computed tomography image, we calculated the muscle thresholds. The software program calculated the HU<sub>ESMcsa</sub> (indicated in blue). (A) Muscle atrophy: HU<sub>ESMcsa</sub> 975.8 cm<sup>2</sup>. (B) Muscle hypertrophy: HU<sub>ESMcsa</sub> 5,910.1 cm<sup>2</sup>. HU, Hounsfield unit; HU<sub>ESMcsa</sub>, Hounsfield unit of average intensity value of erector spinae muscle in cross-sectional area in computed tomography.</p></caption>
<graphic xlink:href="crt-2021-769f1.gif"/></fig>
<fig id="f2-crt-2021-769" position="float">
<label>Fig. 2</label>
<caption>
<p>Flowchart of patient classification according to rehabilitation and propensity score matching.</p></caption>
<graphic xlink:href="crt-2021-769f2.gif"/></fig>
<fig id="f3-crt-2021-769" position="float">
<label>Fig. 3</label>
<caption>
<p>Correlation analysis of pulmonary function test parameters and the HU<sub>ESMcsa</sub>: Forced expiratory volume in 1 second (FEV<sub>1</sub>) (A) and forced vital capacity (FVC) (B). HU, Hounsfieldunit; HU<sub>ESMcsa</sub>, Hounsfieldunit of average intensity value of erector spinae muscle in cross-sectional area in computed tomography.</p></caption>
<graphic xlink:href="crt-2021-769f3.gif"/></fig>
<table-wrap id="t1-crt-2021-769" position="float">
<label>Table 1</label>
<caption>
<p>Baseline characteristics in the rehabilitation and non-rehabilitation groups before and after propensity score matching</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left">Characteristic</th>
<th colspan="4" valign="middle" align="center">Before matching</th>
<th colspan="4" valign="middle" align="center">After matching</th></tr>
<tr>
<th colspan="4" valign="middle" align="center">
<hr/></th>
<th colspan="4" valign="middle" align="center">
<hr/></th></tr>
<tr>
<th valign="middle" align="center">Rehabilitation group (n=75)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=250)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">d</th>
<th valign="middle" align="center">Rehabilitation group (n=45)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=45)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">d</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Age (yr)</bold></td>
<td valign="top" align="center">69.8&#x000B1;7.0</td>
<td valign="top" align="center">64.6&#x000B1;9.2</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">70.0&#x000B1;6.8</td>
<td valign="top" align="center">69.5&#x000B1;6.9</td>
<td valign="top" align="center">0.713</td>
<td valign="top" align="center">0.0730</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Sex</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Male</td>
<td valign="top" align="center">59 (78.7)</td>
<td valign="top" align="center">137 (54.8)</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">30 (66.7)</td>
<td valign="top" align="center">34 (75.6)</td>
<td valign="top" align="center">0.352</td>
<td valign="top" align="center">0.2400</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Female</td>
<td valign="top" align="center">16 (21.3)</td>
<td valign="top" align="center">113 (45.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">15 (33.3)</td>
<td valign="top" align="center">11 (24.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left"><bold>Height (cm)</bold></td>
<td valign="top" align="center">163.5&#x000B1;7.7</td>
<td valign="top" align="center">161.8&#x000B1;8.5</td>
<td valign="top" align="center">0.116</td>
<td valign="top" align="center">0.2042</td>
<td valign="top" align="center">162.7&#x000B1;8.3</td>
<td valign="top" align="center">163.3&#x000B1;7.7</td>
<td valign="top" align="center">0.709</td>
<td valign="top" align="center">0.0749</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left"><bold>Weight (kg)</bold></td>
<td valign="top" align="center">64.8&#x000B1;10.2</td>
<td valign="top" align="center">63.0&#x000B1;8.5</td>
<td valign="top" align="center">0.203</td>
<td valign="top" align="center">0.2018</td>
<td valign="top" align="center">63.7&#x000B1;11.3</td>
<td valign="top" align="center">64.9&#x000B1;12.4</td>
<td valign="top" align="center">0.634</td>
<td valign="top" align="center">0.1012</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Smoking status</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Current smoker</td>
<td valign="top" align="center">5 (6.7)</td>
<td valign="top" align="center">23 (9.2)</td>
<td valign="top" align="center">0.618</td>
<td valign="top" align="center">0.1294</td>
<td valign="top" align="center">4 (8.9)</td>
<td valign="top" align="center">5 (11.1)</td>
<td valign="top" align="center">0.621</td>
<td valign="top" align="center">0.2032</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Ex-smoker</td>
<td valign="top" align="center">23 (30.7)</td>
<td valign="top" align="center">85 (34.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">17 (37.8)</td>
<td valign="top" align="center">21 (46.7)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Non-smoker</td>
<td valign="top" align="center">47 (62.7)</td>
<td valign="top" align="center">142 (56.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">24 (53.3)</td>
<td valign="top" align="center">19 (42.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Comorbidities</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;COPD</td>
<td valign="top" align="center">19 (25.3)</td>
<td valign="top" align="center">71 (28.4)</td>
<td valign="top" align="center">0.603</td>
<td valign="top" align="center">0.0861</td>
<td valign="top" align="center">17 (37.8)</td>
<td valign="top" align="center">21 (46.7)</td>
<td valign="top" align="center">0.393</td>
<td valign="top" align="center">0.2015</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Asthma</td>
<td valign="top" align="center">1 (1.3)</td>
<td valign="top" align="center">8 (3.2)</td>
<td valign="top" align="center">0.690</td>
<td valign="top" align="center">0.4932</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.3948</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;IPF</td>
<td valign="top" align="center">1 (1.3)</td>
<td valign="top" align="center">6 (2.4)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.3301</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.3948</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Hypertension</td>
<td valign="top" align="center">39 (52.0)</td>
<td valign="top" align="center">129 (51.6)</td>
<td valign="top" align="center">0.952</td>
<td valign="top" align="center">0.0088</td>
<td valign="top" align="center">26 (57.8)</td>
<td valign="top" align="center">25 (55.6)</td>
<td valign="top" align="center">0.832</td>
<td valign="top" align="center">0.0499</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Diabetes</td>
<td valign="top" align="center">17 (22.7)</td>
<td valign="top" align="center">59 (23.6)</td>
<td valign="top" align="center">0.867</td>
<td valign="top" align="center">0.0289</td>
<td valign="top" align="center">10 (22.2)</td>
<td valign="top" align="center">8 (17.8)</td>
<td valign="top" align="center">0.598</td>
<td valign="top" align="center">0.1537</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Coronary artery disease</td>
<td valign="top" align="center">13 (17.3)</td>
<td valign="top" align="center">38 (15.2)</td>
<td valign="top" align="center">0.656</td>
<td valign="top" align="center">0.0865</td>
<td valign="top" align="center">8 (17.8)</td>
<td valign="top" align="center">13 (28.9)</td>
<td valign="top" align="center">0.213</td>
<td valign="top" align="center">0.3477</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Cerebrovascular accident</td>
<td valign="top" align="center">4 (5.3)</td>
<td valign="top" align="center">21 (8.4)</td>
<td valign="top" align="center">0.382</td>
<td valign="top" align="center">0.2686</td>
<td valign="top" align="center">5 (11.1)</td>
<td valign="top" align="center">5 (11.1)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.0000</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Inhaler use</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;LAMA</td>
<td valign="top" align="center">1 (1.3)</td>
<td valign="top" align="center">2 (0.8)</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">0.5769</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0.795</td>
<td valign="top" align="center">0.0343</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;LABA+LAMA</td>
<td valign="top" align="center">19 (25.3)</td>
<td valign="top" align="center">25 (10.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">10 (22.2)</td>
<td valign="top" align="center">9 (20.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;ICS+LABA</td>
<td valign="top" align="center">6 (8.0)</td>
<td valign="top" align="center">5 (2.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">4 (8.9)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Triple therapy</td>
<td valign="top" align="center">2 (2.7)</td>
<td valign="top" align="center">1 (0.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;None</td>
<td valign="top" align="center">47 (62.7)</td>
<td valign="top" align="center">217 (86.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">32 (71.1)</td>
<td valign="top" align="center">31 (68.9)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Cancer-related treatment</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Neoadjuvant chemotherapy</td>
<td valign="top" align="center">5 (6.7)</td>
<td valign="top" align="center">12 (4.8)</td>
<td valign="top" align="center">0.556</td>
<td valign="top" align="center">0.1920</td>
<td valign="top" align="center">3 (6.7)</td>
<td valign="top" align="center">4 (8.9)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.1719</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Neoadjuvant concurrent chemoradiotherapy</td>
<td valign="top" align="center">7 (9.3)</td>
<td valign="top" align="center">6 (2.4)</td>
<td valign="top" align="center">0.014</td>
<td valign="top" align="center">0.7894</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.0000</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Type of surgery</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Lobectomy</td>
<td valign="top" align="center">39 (52.0)</td>
<td valign="top" align="center">177 (70.8)</td>
<td valign="top" align="center">0.006</td>
<td valign="top" align="center">0.3175</td>
<td valign="top" align="center">30 (66.7)</td>
<td valign="top" align="center">31 (68.9)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0.0000</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Segmentectomy</td>
<td valign="top" align="center">13 (17.3)</td>
<td valign="top" align="center">33 (13.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">5 (11.1)</td>
<td valign="top" align="center">5 (11.1)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Wedge resection</td>
<td valign="top" align="center">4 (5.3)</td>
<td valign="top" align="center">5 (2.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Bilobectomy</td>
<td valign="top" align="center">5 (6.7)</td>
<td valign="top" align="center">3 (1.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">3 (6.7)</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Lobectomy and segmentectomy</td>
<td valign="top" align="center">4 (5.3)</td>
<td valign="top" align="center">5 (2.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Lobectomy and wedge resection</td>
<td valign="top" align="center">10 (13.3)</td>
<td valign="top" align="center">27 (10.8)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">5 (11.1)</td>
<td valign="top" align="center">6 (13.3)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td colspan="9" valign="top" align="left"><bold>Operation site</bold></td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Right upper lobe</td>
<td valign="top" align="center">16 (21.3)</td>
<td valign="top" align="center">62 (24.8)</td>
<td valign="top" align="center">0.154</td>
<td valign="top" align="center">0.2261</td>
<td valign="top" align="center">12 (26.7)</td>
<td valign="top" align="center">8 (17.8)</td>
<td valign="top" align="center">0.882</td>
<td valign="top" align="center">0.1138</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Right middle lobe</td>
<td valign="top" align="center">1 (1.3)</td>
<td valign="top" align="center">15 (6.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Right lower lobe</td>
<td valign="top" align="center">15 (20.0)</td>
<td valign="top" align="center">43 (17.2)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">7 (15.6)</td>
<td valign="top" align="center">11 (24.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Left upper lobe</td>
<td valign="top" align="center">14 (18.7)</td>
<td valign="top" align="center">61 (24.4)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">10 (22.2)</td>
<td valign="top" align="center">9 (20.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Left lower lobe</td>
<td valign="top" align="center">10 (13.3)</td>
<td valign="top" align="center">34 (13.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">6 (13.3)</td>
<td valign="top" align="center">7 (15.6)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Two or more lobes</td>
<td valign="top" align="center">19 (25.3)</td>
<td valign="top" align="center">35 (14.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">9 (20.0)</td>
<td valign="top" align="center">9 (20.0)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-crt-2021-769">
<p>Values are presented as mean&#x000B1;SD or number (&#x00025;). COPD, chronic obstructive pulmonary disease; d, standardized mean difference; ICS, inhaled corticosteroids; IPF, idiopathic pulmonary fibrosis; LABA, long acting B agonist bronchodilator; LAMA, long acting antimuscarinic agent bronchodilator; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t2-crt-2021-769" position="float">
<label>Table 2</label>
<caption>
<p>Preoperative pulmonary function test data before and after propensity score matching</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left">Pulmonary function test parameter (before surgery)</th>
<th colspan="4" valign="middle" align="center">Before matching</th>
<th colspan="4" valign="middle" align="center">After matching</th></tr>
<tr>
<th colspan="4" valign="middle" align="center">
<hr/></th>
<th colspan="4" valign="middle" align="center">
<hr/></th></tr>
<tr>
<th valign="middle" align="center">Rehabilitation group (n=75)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=250)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">d</th>
<th valign="middle" align="center">Rehabilitation group (n=45)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=45)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">d</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">&#x00394;FEV<sub>1</sub> (L)</td>
<td valign="top" align="center">2.2&#x000B1;0.6</td>
<td valign="top" align="center">2.5&#x000B1;0.6</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">2.3&#x000B1;0.6</td>
<td valign="top" align="center">2.4&#x000B1;0.5</td>
<td valign="top" align="center">0.310</td>
<td valign="top" align="center">0.1811</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;FEV<sub>1</sub> (&#x00025;)</td>
<td valign="top" align="center">78.9&#x000B1;15.0</td>
<td valign="top" align="center">91.7&#x000B1;13.6</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">83.9&#x000B1;14.6</td>
<td valign="top" align="center">86.3&#x000B1;13.5</td>
<td valign="top" align="center">0.431</td>
<td valign="top" align="center">0.1707</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;FVC (L)</td>
<td valign="top" align="center">3.4&#x000B1;0.9</td>
<td valign="top" align="center">3.5&#x000B1;0.8</td>
<td valign="top" align="right">0.334</td>
<td valign="top" align="center">0.1214</td>
<td valign="top" align="center">3.4&#x000B1;0.9</td>
<td valign="top" align="center">3.5&#x000B1;0.8</td>
<td valign="top" align="center">0.322</td>
<td valign="top" align="center">0.1174</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;FVC (&#x00025;)</td>
<td valign="top" align="center">85.4&#x000B1;14.4</td>
<td valign="top" align="center">93.3&#x000B1;11.8</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">88.0&#x000B1;14.6</td>
<td valign="top" align="center">90.6&#x000B1;11.4</td>
<td valign="top" align="center">0.350</td>
<td valign="top" align="center">0.1985</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">FEV<sub>1</sub>/FVC</td>
<td valign="top" align="center">65.6&#x000B1;10.9</td>
<td valign="top" align="center">73.2&#x000B1;8.7</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">68.1&#x000B1;9.7</td>
<td valign="top" align="center">67.8&#x000B1;8.4</td>
<td valign="top" align="center">0.853</td>
<td valign="top" align="center">0.0331</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">DL<sub>CO</sub> (L)</td>
<td valign="top" align="center">14.3&#x000B1;3.3</td>
<td valign="top" align="center">16.9&#x000B1;3.9</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">14.8&#x000B1;3.1</td>
<td valign="top" align="center">15.6&#x000B1;3.9</td>
<td valign="top" align="center">0.290</td>
<td valign="top" align="center">0.2271</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">DL<sub>CO</sub> (&#x00025;)</td>
<td valign="top" align="center">75.7&#x000B1;14.8</td>
<td valign="top" align="center">87.3&#x000B1;14.9</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">79.8&#x000B1;13.6</td>
<td valign="top" align="center">81.9&#x000B1;15.3</td>
<td valign="top" align="center">0.482</td>
<td valign="top" align="center">0.1451</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">DL<sub>CO</sub>/VA (L)</td>
<td valign="top" align="center">3.2&#x000B1;0.8</td>
<td valign="top" align="center">3.7&#x000B1;0.7</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">3.4&#x000B1;0.8</td>
<td valign="top" align="center">3.3&#x000B1;0.7</td>
<td valign="top" align="center">0.728</td>
<td valign="top" align="center">0.1330</td></tr>
<tr>
<td colspan="9" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">DL<sub>CO</sub>/VA (&#x00025;)</td>
<td valign="top" align="center">85.2&#x000B1;18.1</td>
<td valign="top" align="center">93.4&#x000B1;15.8</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">Infinity</td>
<td valign="top" align="center">88.4&#x000B1;18.0</td>
<td valign="top" align="center">87.3&#x000B1;16.9</td>
<td valign="top" align="center">0.773</td>
<td valign="top" align="center">0.0630</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn2-crt-2021-769">
<p>Values are presented as mean&#x000B1;SD. d, standardized mean difference; DL<sub>CO</sub>, carbon monoxide diffusing capacity; FEV<sub>1</sub>, forced expiratory volume in 1 second; FVC, forced vital capacity; VA, alveolar volume.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t3-crt-2021-769" position="float">
<label>Table 3</label>
<caption>
<p>Differences in postoperative lung function before and after propensity score matching</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left">Pulmonary function test parameter</th>
<th colspan="3" valign="middle" align="center">Before matching</th>
<th colspan="3" valign="middle" align="center">After matching</th></tr>
<tr>
<th colspan="3" valign="middle" align="center">
<hr/></th>
<th colspan="3" valign="middle" align="center">
<hr/></th></tr>
<tr>
<th valign="middle" align="center">Rehabilitation group (n=75)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=250)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">Rehabilitation group (n=45)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=45)</th>
<th valign="middle" align="center">p-value</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">&#x00394;FEV<sub>1</sub> (L)</td>
<td valign="top" align="center">&#x02212;0.3&#x000B1;0.3</td>
<td valign="top" align="center">&#x02212;0.5&#x000B1;0.3</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">&#x02212;0.3&#x000B1;0.3</td>
<td valign="top" align="center">&#x02212;0.5&#x000B1;0.3</td>
<td valign="top" align="center">0.001</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;FEV<sub>1</sub> (&#x00025;)</td>
<td valign="top" align="center">&#x02212;10.5&#x000B1;9.0</td>
<td valign="top" align="center">&#x02212;19.0&#x000B1;10.9</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">&#x02212;11.6&#x000B1;9.3</td>
<td valign="top" align="center">&#x02212;18.8&#x000B1;11.0</td>
<td valign="top" align="center">0.001</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;FVC (L)</td>
<td valign="top" align="center">&#x02212;0.5&#x000B1;0.4</td>
<td valign="top" align="center">&#x02212;0.7&#x000B1;0.5</td>
<td valign="top" align="right">0.006</td>
<td valign="top" align="center">&#x02212;0.6&#x000B1;0.4</td>
<td valign="top" align="center">&#x02212;0.8&#x000B1;0.5</td>
<td valign="top" align="center">0.019</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;FVC (&#x00025;)</td>
<td valign="top" align="center">&#x02212;13.8&#x000B1;9.5</td>
<td valign="top" align="center">&#x02212;18.9&#x000B1;11.3</td>
<td valign="top" align="right">&lt; 0.001</td>
<td valign="top" align="center">&#x02212;14.4&#x000B1;9.8</td>
<td valign="top" align="center">&#x02212;20.7&#x000B1;12.7</td>
<td valign="top" align="center">0.010</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;DL<sub>CO</sub> (L)</td>
<td valign="top" align="center">&#x02212;1.9&#x000B1;2.4</td>
<td valign="top" align="center">&#x02212;2.7&#x000B1;2.6</td>
<td valign="top" align="right">0.021</td>
<td valign="top" align="center">&#x02212;1.9&#x000B1;2.4</td>
<td valign="top" align="center">&#x02212;2.4&#x000B1;3.3</td>
<td valign="top" align="center">0.385</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;DL<sub>CO</sub> (&#x00025;)</td>
<td valign="top" align="center">&#x02212;10.2&#x000B1;12.0</td>
<td valign="top" align="center">&#x02212;14.0&#x000B1;13.3</td>
<td valign="top" align="right">0.029</td>
<td valign="top" align="center">&#x02212;10.4&#x000B1;12.0</td>
<td valign="top" align="center">&#x02212;13.2&#x000B1;16.1</td>
<td valign="top" align="center">0.364</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;DL<sub>CO</sub>/VA (L)</td>
<td valign="top" align="center">0.0&#x000B1;0.5</td>
<td valign="top" align="center">0.1&#x000B1;0.5</td>
<td valign="top" align="right">0.572</td>
<td valign="top" align="center">0.0&#x000B1;0.4</td>
<td valign="top" align="center">0.2&#x000B1;0.6</td>
<td valign="top" align="center">0.193</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394;DL<sub>CO</sub>/VA (&#x00025;)</td>
<td valign="top" align="center">1.0&#x000B1;11.9</td>
<td valign="top" align="center">1.8&#x000B1;12.7</td>
<td valign="top" align="right">0.617</td>
<td valign="top" align="center">1.0&#x000B1;9.9</td>
<td valign="top" align="center">4.3&#x000B1;14.6</td>
<td valign="top" align="center">0.210</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn3-crt-2021-769">
<p>Values are presented as mean&#x000B1;SD. &#x00394;, differences before and after surgery; DL<sub>CO</sub>, carbon monoxide diffusing capacity; FEV<sub>1</sub>, forced expiratory volume in 1 second; FVC, forced vital capacity; VA, alveolar volume.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t4-crt-2021-769" position="float">
<label>Table 4</label>
<caption>
<p>HU<sub>ESMcsa</sub> measurement using computed tomography images</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left"/>
<th colspan="3" valign="middle" align="center">Before matching</th>
<th colspan="3" valign="middle" align="center">After matching</th></tr>
<tr>
<th colspan="3" valign="middle" align="center">
<hr/></th>
<th colspan="3" valign="middle" align="center">
<hr/></th></tr>
<tr>
<th valign="middle" align="center">Rehabilitation group (n=75)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=250)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">Rehabilitation group (n=45)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=45)</th>
<th valign="middle" align="center">p-value</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Before surgery (cm<sub>2</sub>)</td>
<td valign="top" align="center">3,717.6&#x000B1;823.0</td>
<td valign="top" align="center">3,712.3&#x000B1;970.0</td>
<td valign="top" align="center">0.966</td>
<td valign="top" align="center">3,580.4&#x000B1;829.0</td>
<td valign="top" align="center">3,787.9&#x000B1;1271.9</td>
<td valign="top" align="center">0.362</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394; HU<sub>ESMcsa</sub></td>
<td valign="top" align="center">&#x02212;15.6&#x000B1;166.5</td>
<td valign="top" align="center">&#x02212;159.6&#x000B1;199.0</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">&#x02212;22.6&#x000B1;152.8</td>
<td valign="top" align="center">&#x02212;136.4&#x000B1;172.7</td>
<td valign="top" align="center">0.001</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x00394; HU<sub>ESMcsa</sub> (&#x00025;)</td>
<td valign="top" align="center">&#x02212;0.4&#x000B1;4.6</td>
<td valign="top" align="center">&#x02212;4.0&#x000B1;5.2</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">&#x02212;0.6&#x000B1;4.4</td>
<td valign="top" align="center">&#x02212;3.4&#x000B1;4.1</td>
<td valign="top" align="center">0.003</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn4-crt-2021-769">
<p>Values are presented as mean&#x000B1;standard deviation. &#x00394;, differences before and after surgery; HU, Hounsfield unit; HU<sub>ESMcsa</sub>, Hounsfield unit of average intensity value of erector spinae muscle in cross-sectional area in computed tomography.</p></fn><fn id="tfn5-crt-2021-769">
<p>HU<sub>ESMcsa</sub> (&#x00025;)=Postoperation HU<sub>ESMcsa</sub>&#x02013;Preoperation HU<sub>ESMcsa</sub>/Preoperation HU<sub>ESMcsa</sub>&#x000D7;100.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t5-crt-2021-769" position="float">
<label>Table 5</label>
<caption>
<p>Clinical outcomes related to surgery</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left"/>
<th colspan="3" valign="middle" align="center">Before matching</th>
<th colspan="3" valign="middle" align="center">After matching</th></tr>
<tr>
<th colspan="3" valign="middle" align="center">
<hr/></th>
<th colspan="3" valign="middle" align="center">
<hr/></th></tr>
<tr>
<th valign="middle" align="center">Rehabilitation group (n=75)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=250)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">Rehabilitation group (n=45)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=45)</th>
<th valign="middle" align="center">p-value</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Period from admission to discharge (day)</td>
<td valign="top" align="center">10.1&#x000B1;6.0</td>
<td valign="top" align="center">8.4&#x000B1;4.3</td>
<td valign="top" align="center">0.029</td>
<td valign="top" align="center">9.3&#x000B1;6.2</td>
<td valign="top" align="center">9.4&#x000B1;5.0</td>
<td valign="top" align="center">0.926</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">HFNC application</td>
<td valign="top" align="center">68 (90.7)</td>
<td valign="top" align="center">219 (87.6)</td>
<td valign="top" align="center">0.469</td>
<td valign="top" align="center">41 (91.1)</td>
<td valign="top" align="center">35 (77.8)</td>
<td valign="top" align="center">0.081</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">Duration of HFNC use</td>
<td valign="top" align="center">3.2&#x000B1;1.8</td>
<td valign="top" align="center">2.9&#x000B1;1.6</td>
<td valign="top" align="center">0.171</td>
<td valign="top" align="center">3.4&#x000B1;2.0</td>
<td valign="top" align="center">3.4&#x000B1;1.8</td>
<td valign="top" align="center">0.982</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">90-Day mortality</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (0.4)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">180-Day mortality</td>
<td valign="top" align="center">2 (2.7)</td>
<td valign="top" align="center">3 (1.2)</td>
<td valign="top" align="center">0.326</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">&gt; 0.99</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn6-crt-2021-769">
<p>Values are presented as mean&#x000B1;SD or number (&#x00025;). HFNC, high-flow nasal cannula.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t6-crt-2021-769" position="float">
<label>Table 6</label>
<caption>
<p>Major postoperative complications (occurrence within 1 month)</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left"/>
<th colspan="3" valign="middle" align="center">Before matching</th>
<th colspan="3" valign="middle" align="center">After matching</th></tr>
<tr>
<th colspan="3" valign="middle" align="center">
<hr/></th>
<th colspan="3" valign="middle" align="center">
<hr/></th></tr>
<tr>
<th valign="middle" align="center">Rehabilitation group (n=75)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=250)</th>
<th valign="middle" align="center">p-value</th>
<th valign="middle" align="center">Rehabilitation group (n=45)</th>
<th valign="middle" align="center">Non-rehabilitation group (n=45)</th>
<th valign="middle" align="center">p-value</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Total</bold><xref rid="tfn8-crt-2021-769" ref-type="table-fn"><sup>a)</sup></xref></td>
<td valign="top" align="center">10 (13.3)</td>
<td valign="top" align="center">50 (20.0)</td>
<td valign="top" align="center">0.192</td>
<td valign="top" align="center">4 (8.9)</td>
<td valign="top" align="center">12 (26.7)</td>
<td valign="top" align="center">0.027</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;When two or more different events occur</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2 (0.8)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Major cardiovascular events or arrhythmia</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">5 (2.0)</td>
<td valign="top" align="center">0.593</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Pneumonia</td>
<td valign="top" align="center">3 (4.0)</td>
<td valign="top" align="center">6 (2.4)</td>
<td valign="top" align="center">0.436</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Pneumothorax</td>
<td valign="top" align="center">3 (4.0)</td>
<td valign="top" align="center">9 (3.6)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Chest pain or dyspnea</td>
<td valign="top" align="center">1 (1.3)</td>
<td valign="top" align="center">8 (3.2)</td>
<td valign="top" align="center">0.690</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Pulmonary embolism or deep vein thrombosis</td>
<td valign="top" align="center">3 (4.0)</td>
<td valign="top" align="center">19 (7.6)</td>
<td valign="top" align="center">0.276</td>
<td valign="top" align="center">2 (4.4)</td>
<td valign="top" align="center">8 (17.8)</td>
<td valign="top" align="center">0.044</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Pleural effusion</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2 (0.8)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">&gt; 0.99</td></tr>
<tr>
<td colspan="7" valign="bottom" align="left">
<hr/></td></tr>
<tr>
<td valign="top" align="left">&#x02003;Etc.<xref rid="tfn9-crt-2021-769" ref-type="table-fn"><sup>b)</sup></xref></td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">3 (1.2)</td>
<td valign="top" align="center">&gt; 0.99</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (2.2)</td>
<td valign="top" align="center">&gt; 0.99</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn7-crt-2021-769">
<p>Values are presented as number (&#x00025;).</p></fn><fn id="tfn8-crt-2021-769">
<label>a)</label>
<p>All cases where &#x02018;hospitalization&#x02019; or &#x02018;visit the emergency room&#x02019; or &#x02018;intervention (procedure or anticoagulation) was added&#x02019; within one month for the reasons listed in the table,</p></fn><fn id="tfn9-crt-2021-769">
<label>b)</label>
<p>Etc. contains dizziness or general weakness.</p></fn></table-wrap-foot></table-wrap></sec></back></article>
